As of Nov 25
| +0.0193 / +1.45%|
The 1 analysts offering 12-month price forecasts for Skystar Bio-Pharmaceutical Co have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +85.28% increase from the last price of 1.35.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.